Public signalCompany raiseAuto-indexed · Unverified

Aclaris Therapeutics, Inc. raised $80.0M

Aclaris Therapeutics, Inc.· WAYNE, US· Pharmaceuticals· Filed Dec 4, 2024

Aclaris Therapeutics, Inc. reported raising capital. Based in WAYNE, PENNSYLVANIA, US. First sale reported 2024-11-19. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$80.0M
Confidence90%
Raised
$80.0M
Investors
19
Jurisdiction
DELAWARE

On the record

Location
WAYNE, US
Sector
Pharmaceuticals
Record type
Company raise
Stage
Reported raised
Amount raised
$80.0M
Target amount
$80.0M
Filing date
Dec 4, 2024
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Industry group
Pharmaceuticals
Number of investors
19
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$80.0M
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 79,999,999 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Dec 4, 2024. Details beyond the filing have not been verified.

Tags

USCompanyPharmaceuticals$10M – $100MCompany Raise

Are you associated with Aclaris Therapeutics, Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record